Related references
Note: Only part of the references are listed.aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2
Jia Sun et al.
REDOX BIOLOGY (2021)
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Yan Zheng et al.
NATURE REVIEWS ENDOCRINOLOGY (2018)
Edaravone Improves Septic Cardiac Function by Inducing an HIF-1α/HO-1 Pathway
Chao He et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis
Chun-Yuan Chen et al.
THERANOSTICS (2018)
AMP-Activated Protein Kinase α2 in Neutrophils Regulates Vascular Repair via Hypoxia-Inducible Factor-1α and a Network of Proteins Affecting Metabolism and Apoptosis
Randa Abdel Malik et al.
CIRCULATION RESEARCH (2017)
Diabetic Foot Ulcers and Their Recurrence
David G. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes
Julien Wils et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Estradiol effects on hypothalamic AMPK and BAT thermogenesis: A gateway for obesity treatment?
Miguel Lopez et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases
Lina Zhao et al.
STEM CELL RESEARCH & THERAPY (2017)
AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species
Rebecca C. Rabinovitch et al.
CELL REPORTS (2017)
Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds
Patricia J. McLaughlin et al.
ADVANCES IN WOUND CARE (2017)
Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice
Teruo Jojima et al.
ATHEROSCLEROSIS (2017)
Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice
Jia-Wen Yu et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Protective Roles of Endothelial AMP-Activated Protein Kinase Against Hypoxia-Induced Pulmonary Hypertension in Mice
Junichi Omura et al.
CIRCULATION RESEARCH (2016)
Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together
Xianwei Wang et al.
CLINICAL SCIENCE (2016)
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells
Bastien Gerby et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The AMPKα1 Pathway Positively Regulates the Developmental Transition from Proliferation to Quiescence in Trypanosoma brucei
Manuel Saldivia et al.
CELL REPORTS (2016)
AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages
Yun Wang et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats
Tomoaki Inoue et al.
ATHEROSCLEROSIS (2015)
MicroRNA-132 enhances transition from inflammation to proliferation during wound healing
Dongqing Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Sirtuin 6 Expression and Inflammatory Activity in Diabetic Atherosclerotic Plaques: Effects of Incretin Treatment
Maria Luisa Balestrieri et al.
DIABETES (2015)
Endothelial PGC-1α Mediates Vascular Dysfunction in Diabetes
Naoki Sawada et al.
CELL METABOLISM (2014)
AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation
Jiun-Tsai Lin et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)
Priming with proangiogenic growth factors and endothelial progenitor cells improves revascularization in linear diabetic wounds
Maximilian Ackermann et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential
Hiroki Fujita et al.
KIDNEY INTERNATIONAL (2014)
Induction of Vascular Insulin Resistance and Endothelin-1 Expression and Acceleration of Atherosclerosis by the Overexpression of Protein Kinase C- Isoform in the Endothelium
Qian Li et al.
CIRCULATION RESEARCH (2013)
Diabetes Mellitus-Associated Vascular Impairment Novel Circulating Biomarkers and Therapeutic Approaches
Dimitris Tousoulis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Endothelium-Selective Activation of AMP-Activated Protein Kinase Prevents Diabetes Mellitus-Induced Impairment in Vascular Function and Reendothelialization via Induction of Heme Oxygenase-1 in Mice
Francois Y. L. Li et al.
CIRCULATION (2012)
Harnessing the incretin system beyond glucose control: Potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetes
B. Cariou
DIABETES & METABOLISM (2012)
Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes
C. F. Bento et al.
DIABETOLOGIA (2011)
Amp-activated protein kinase activation as a strategy for protecting vascular endothelial function
Ming-Hui Zou et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study
L. Prompers et al.
DIABETOLOGIA (2008)
Improvement of endothelial function by systemic transfusion of vascular progenitor cells
Sven Wassmann et al.
CIRCULATION RESEARCH (2006)
Activation of AMP-activated protein kinase reduces hyperglycemia-Induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells
D Kukidome et al.
DIABETES (2006)
Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells - Inhibition by the AMP-activated protein kinase activation
Y Ido et al.
DIABETES (2002)
Share Paper
